HCSG EVP exercises options, sells 45,500 shares

Healthcare Services Group Inc. executive Patrick J. Orr, EVP & Chief Revenue Officer, reported multiple stock option exercises and a share sale.

Accepted by SEC EDGAR 02/19/2026 - 08:36 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Healthcare Services Group Inc. executive Patrick J. Orr, EVP & Chief Revenue Officer, reported multiple stock option exercises and a share sale. On February 18, 2026, he exercised several stock option grants, lifting his direct common stock holdings to 90,115 shares before selling 45,500 shares in an open-market transaction at $20.54 per share, ending with 44,615 shares held directly.

Insider Trade Summary

Exercise and Sale: 45,500 shares ($269K approx. pre-tax spread)

Exercise and Sale 9 txns

Insider Orr Patrick J

Role EVP & Chief Revenue Officer

Sold 45,500 shs ($935K)

Approx. gross sale proceeds $935K

Approx. exercise cost $665K

Approx. pre-tax spread $269K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	21,075	$0.00	$0.00
Exercise	Stock Option (right to buy)	7,016	$0.00	$0.00
Exercise	Stock Option (right to buy)	12,216	$0.00	$0.00
Exercise	Stock Option (right to buy)	5,193	$0.00	$0.00
Exercise	Common Stock	21,075	$18.10	$381K
Exercise	Common Stock	7,016	$13.72	$96K
Exercise	Common Stock	12,216	$10.36	$127K
Exercise	Common Stock	5,193	$11.76	$61K
Sale	Common Stock	45,500	$20.54	$935K

Holdings After Transaction: Stock Option (right to buy) — 54,886 contracts (Direct); Common Stock — 44,615 shares (Direct)

Footnotes (4)

1. F1. These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date.
2. F2. These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the February 24, 2023 grant date.
3. F3. These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2024 grant date.
4. F4. These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2025 grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HCSG executive Patrick J. Orr report?

Patrick J. Orr reported exercising multiple stock options and selling common shares. On February 18, 2026, he converted options into Healthcare Services Group common stock, then sold 45,500 shares in an open-market transaction, leaving him with 44,615 shares held directly afterward.

How many Healthcare Services Group (HCSG) shares did Patrick J. Orr sell?

Patrick J. Orr sold 45,500 shares of Healthcare Services Group common stock. The transaction was reported as an open-market sale at a price of $20.54 per share, reducing his directly held position to 44,615 shares following the sale.

At what price were Patrick J. Orr’s HCSG shares sold in the reported Form 4?

The reported sale was executed at $20.54 per share. This price applied to 45,500 Healthcare Services Group common shares sold in an open-market transaction on February 18, 2026, as disclosed in the Form 4 insider trading report.

Did Patrick J. Orr increase or decrease his HCSG holdings overall?

Patrick J. Orr both acquired and sold shares in related transactions. He exercised stock options to acquire common stock, then sold 45,500 shares, ending with 44,615 shares directly owned. Overall activity reflects a combination of option exercises and a net share reduction.

What type of derivative transactions did HCSG’s Patrick J. Orr report?

He reported multiple stock option exercises, categorized as derivative securities. Each transaction converted stock options into Healthcare Services Group common shares, with footnotes indicating these options vest 20% annually starting one year after their respective grant dates.

What vesting schedule applies to Patrick J. Orr’s reported HCSG stock options?

The reported stock options vest at 20% per year. Vesting begins on the first anniversary of each grant date—January 4, 2022, February 24, 2023, January 3, 2024, and January 3, 2025—after which portions become exercisable annually according to the disclosed schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Orr Patrick J

(Last) (First) (Middle)

3220 TILLMAN DRIVE

SUITE 300

(Street)

BENSALEM PA 19020

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Revenue Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		M		21,075	A	$18.1	65,690	D
Common Stock	02/18/2026		M		7,016	A	$13.72	72,706	D
Common Stock	02/18/2026		M		12,216	A	$10.36	84,922	D
Common Stock	02/18/2026		M		5,193	A	$11.76	90,115	D
Common Stock	02/18/2026		S		45,500	D	$20.54	44,615	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$18.1	02/18/2026		M			21,075	(1)	01/04/2032	Common Stock	21,075	$0	5,268	D
Stock Option (right to buy)	$13.72	02/18/2026		M			7,016	(2)	02/24/2033	Common Stock	7,016	$0	10,524	D
Stock Option (right to buy)	$10.36	02/18/2026		M			12,216	(3)	01/03/2034	Common Stock	12,216	$0	18,322	D
Stock Option (right to buy)	$11.76	02/18/2026		M			5,193	(4)	01/03/2035	Common Stock	5,193	$0	20,772	D

Explanation of Responses:

1. These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date.

2. These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the February 24, 2023 grant date.

3. These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2024 grant date.

4. These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2025 grant date.

Remarks:

	Michael Harrity, by Power of Attorney	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.